Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Colonic Neoplasms × Selenium × Clear all

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 7 Male Urogenital Diseases 2 Urinary Bladder Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Thyroid Nodule 1 Polyps 1 Ovarian Neoplasms 1 Non-melanoma Skin Cancer 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Inflammation 1 Fallopian Tube Neoplasms 1 Colonic Neoplasms 1 Arsenic Poisoning 1

Interventions

Oxaliplatin 101 Fluorouracil 93 Leucovorin 81 Irinotecan 79 Capecitabine 50 Bevacizumab 49 Cetuximab 36 Folfox protocol 24 Colonoscopy 20 Chemotherapy, Adjuvant 18 Blood Specimen Collection 17 Drug Therapy 16 Nivolumab 15 Exercise 15 Radiotherapy 14 Panitumumab 14 Surveys and Questionnaires 13 Early Intervention, Educational 13 Laparoscopy 12 Floxuridine 12 pembrolizumab 11 XELOX 11 trifluridine tipiracil drug combination 10 Surgical Procedures, Operative 10 Methods 10 Magnetic Resonance Spectroscopy 10 Aspirin 10 Immunohistochemistry 9 regorafenib 8 Propofol 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05472753 2025-02-12

TERATROFO

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Phase NA Completed

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡